Mammary Cell News Volume 14.08 | Mar 3 2022

    0
    46







    2022-03-03 | MCN 14.08


    Mammary Cell News by STEMCELL Technologies
    Vol. 14.08 – 3 March, 2022
    TOP STORY

    Proteome-Centric Cross-Omics Characterization and Integrated Network Analyses of Triple-Negative Breast Cancer

    Investigators reported a comprehensive proteomic study of a 90-case cohort of paired samples of TNBC in quantification, phosphorylation, and DNA-binding capacity.
    [Cell Reports]

    Full ArticleGraphical Abstract
    Watch the Webinar On-Demand: “Re-Creating Disease with Kidney Organoids and CRISPR-Cas9”
    PUBLICATIONSRanked by the impact factor of the journal

    Effective Targeting of Breast Cancer Stem Cells by Combined Inhibition of Sam68 and Rad51

    Using breast cancer (BC) sphere cells as a model, researchers showed that BC stem-like cells expressed high levels of Myc, which required the presence of the multifunctional DNA/RNA binding protein Sam68 for the DNA-damage repair.
    [Oncogene]

    Full Article

    A Micropeptide XBP1SBM Encoded by lncRNA Promotes Angiogenesis and Metastasis of TNBC via XBP1s Pathway

    Scientists identified a 21-amino-acid survival-associated micropeptide XBP1SBM, encoded by the long non-coding RNA (lncRNA) MLLT4-AS1, which was upregulated in TNBC tissues and glutamine-deprived TNBC cell lines.
    [Oncogene]

    Abstract

    Loss of Function of BRCA1 Promotes EMT in Mammary Tumors through Activation of TGFβR2 Signaling Pathway

    Researchers analyzed murine and human tumors and identified a role for Tgfβr2 in governing the molecular aspects of epithelial to mesenchymal transition that occured with Brca1 loss.
    [Cell Death & Disease]

    Full Article

    Extracellular ATP Promotes Breast Cancer Chemoresistance via HIF-1α Signaling

    The authors reported that hypoxia-inducible factor 1α (HIF-1α) was upregulated after ATP treatment and mediated the ATP-driven chemoresistance process.
    [Cell Death & Disease]

    Full Article

    EIF4A3-Mediated CircPRKCI Expression Promotes Triple-Negative Breast Cancer Progression by Regulating WBP2 and PI3K/AKT Signaling Pathway

    Investigators demonstrated that circular RNA PRKCI (circPRKCI), derived from the PRKCI gene, was elevated in breast cancer tissues and cell lines, especially in TNBC.
    [Cell Death Discovery]

    Full Article

    p53 Reactivating Small Molecule PRIMA-1MET/APR-246 Regulates Genomic Instability in MDA-MB-231 Cells

    The authors investigated the reactivation of p53 in DNA repair mechanisms and the maintenance of genomic stability using PRIMA‑1METAPR‑246 small molecules, in both MDA‑MB‑231 and MCF‑7 breast cancer cell lines.
    [Oncology Reports]

    Abstract

    Knockdown of YAP/TAZ Sensitizes Tamoxifen-Resistant MCF7 Breast Cancer Cells

    Scientists found that the expression level of YAP/TAZ in tamoxifen-resistant MCF7 breast cancer cells was significantly increased compared with that in MCF7 cells.
    [Biochemical and Biophysical Research Communications]

    Full Article

    Laminin N-terminus α31 Is Upregulated in Invasive Ductal Breast Cancer and Changes the Mode of Tumour Invasion

    To study laminin N-terminus α31 (LaNt α31) function, an adenoviral system was used to induce expression in MCF-7 and MDA-MB-231 cells. 2D cell migration and invasion into collagen hydrogels were not significantly different between LaNt α31 overexpressing cells and control treated cells.
    [PLoS One]

    Full Article

    Knockdown of Long Non-Coding RNA DDX11-AS1 Inhibits the Proliferation, Migration and Paclitaxel Resistance of Breast Cancer Cells by Upregulating MicroRNA-497 Expression

    Reverse transcription‑quantitative PCR was used to detect the expression levels of DDX11 antisense RNA 1 (DDX11-AS1) and microRNA‑497 in MCF‑7 and MDA‑MB‑231 cells.
    [Molecular Medicine Reports]

    Full Article
    Scientific resources to support your stem cell research. Learn More!
    REVIEWS

    Unconventional Protein Post-Translational Modifications: The Helmsmen in Breast Cancer

    Investigators illustrate the functions of unconventional post-translational modifications such as acetylation, glycosylation, sumoylation, methylation, ubiquitination, citrullination, and palmitoylation and highlight their impact on the oncogenesis and progression of breast cancer.
    [Cell and Bioscience]

    Full Article

    Role of Non-Coding RNAs in Response of Breast Cancer to Radiation Therapy

    The authors provide a summary of current findings on non-coding RNAs (ncRNAs) dysregulation after irradiation and present the function and mechanism of ncRNAs in modulating radiosensitivity or radioresistance of breast cancer cells.
    [Molecular Biology Reports]

    Abstract
    INDUSTRY AND POLICY NEWS

    Finding Drugs for Formerly Undruggable Cancer Targets: UH Researcher Receives $2M Grant to Innovate Computer-Aided Drug Discovery for Breast Cancer

    With a $2 million recruitment grant from the Cancer Prevention and Research Institute of Texas, a University of Houston (UH) researcher will be setting up a lab to develop drugs that will work on traditionally undruggable targets in cancer.
    [University of Houston]

    Press Release
    FEATURED EVENT

    EHA-SWG Scientific Meeting

    April 7 – April 9
    Rome, Italy & Virtual

    > See All Events

    JOB OPPORTUNITIES

    Research Fellow – Cancer Metabolism and Tumour Immunology

    Monash University – Clayton, Australia

    Postdoctoral Position – Breast Cancer Precision Oncology

    German Cancer Research Center in the Helmholtz Association – Heidelberg, German

    Research Assistant – Breast Cancer

    National University of Ireland Galway – Galway, Ireland

    Postdoctoral Position – Biomolecular NMR

    University of Vienna – Vienna, Austria

    Postdoctoral Fellow – Breast Cancer Organoids

    Cold Spring Harbor Laboratory – Cold Spring Harbor, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mammary Cell News Twitter